Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
about
Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased ageLeucine/valine residues direct oxygenation of linoleic acid by (10R)- and (8R)-dioxygenases: expression and site-directed mutagenesis oF (10R)-dioxygenase with epoxyalcohol synthase activityCandida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of EicosanoidsNitro-fatty acids: novel anti-inflammatory lipid mediatorsMutational and X-ray crystallographic analysis of the interaction of dihomo-gamma -linolenic acid with prostaglandin endoperoxide H synthasesStructure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide HydrolaseIncreased PGE2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of the head and neckThe basis of prostaglandin synthesis in coral: molecular cloning and expression of a cyclooxygenase from the Arctic soft coral Gersemia fruticosaControl of prostaglandin stereochemistry at the 15-carbon by cyclooxygenases-1 and -2. A critical role for serine 530 and valine 349The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitorsCOX-1 and COX-2 expression in osteoid osteomasA three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsOxidation of 4-chlorobiphenyl metabolites to electrophilic species by prostaglandin H synthaseActivation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infectionThe eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanismIntegrated proteomics identified novel activation of dynein IC2-GR-COX-1 signaling in neurofibromatosis type I (NF1) disease model cellsThe leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular functionFluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancerOxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoids2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological EvaluationCharacterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis.Sarsasapogenin-AA13 inhibits LPS-induced inflammatory responses in macrophage cells in vitro and relieves dimethylbenzene-induced ear edema in miceRole of cytosolic phospholipase A(2) in retinal neovascularization.Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products.Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirinBiochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia.Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis.The development of COX2 inhibitors.Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors.Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.Therapeutic potential of COX-2 inhibitors in arthritis.Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.Clinical pharmacology of etoricoxib.Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2.Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.
P2860
Q24631055-8D8E9D8E-1EE9-418F-9999-B56F4FFB6545Q24647930-C4DF7343-8222-4FC2-90E0-F5B6B74BAA38Q26767229-A481A43F-59C9-419C-85F9-F6B3D3E3FC6FQ26853134-FC63AF3C-326C-4CDA-9772-53707C7B59A8Q27628961-60FF24BE-B700-4D81-BD3C-E898320F954AQ27633719-22F26FED-01C1-4BD9-B5A1-5FF2644E3A21Q27675504-073D49B1-25B5-4156-97C3-2563E2E86580Q28173990-16347DA3-35EF-4382-A8C5-F7E2886352DBQ28174723-AF55DF88-BC13-48A9-A1CF-177228BA84D4Q28190707-DE7F147B-4146-4A9C-9C45-EBB357D18AD5Q28192716-C10C925E-950C-4AFD-BCFD-4706052237F8Q28202332-366DDF09-A707-437B-9CB2-655A9738EAD9Q28344403-7E67C866-18C7-4189-9EED-29E914C72CEAQ28387341-CFDDBA9F-AC43-42EA-A328-8486EC6E94F4Q28472541-719A6653-B4FC-4BE7-AE74-80E6EFEFB494Q28533399-A5860330-3348-4856-975E-1F45926CEB78Q28909841-6B485F6B-32BC-4C6E-87FB-90216D3D7096Q30234961-6F1C287C-3245-4376-85A1-8C9A2EC4F79BQ30477135-94F80F0E-A80A-4C4A-8B0B-E7E85C4A6EB9Q30743369-5784E2FD-711F-4D47-8BD1-B2140B935893Q33433330-F60DB590-D484-4A10-95C3-82E2B60F42D5Q33636453-F323A0E4-B548-4809-82D7-3D4F7B880F52Q33701495-3B998BD2-06D9-496C-A737-895B91FD599AQ33759949-FBD5B76D-ECEF-41FB-99CF-F0E0C5925719Q33845292-44257719-890E-48F6-BCC6-7D10E8A6072AQ33893719-4D7E1719-26E6-4BFB-B9EB-D11F139A7B8AQ33903900-3A2B992C-AA12-4591-BEBA-0A83383A6D47Q33952053-B9A2C7AA-CFBE-49B6-853C-EF44A4585D1BQ34082384-71C39562-FCEA-45A9-96C2-E8CE9145B656Q34127214-2D1BAB5A-84BF-41EA-A221-80D41274050DQ34180681-367B5372-7BE6-47A5-86CD-D79378A4B579Q34265980-E9E45EC2-B4BE-4C91-A097-2B1347C70D38Q34395104-4D0E2254-1EC2-4A24-9F83-652894ECDED8Q34481579-EB8D01C9-2855-497C-AACD-8D3EAA5C040AQ34505205-5CE2D305-6597-4520-98AD-9BCCE54A62ACQ34570225-2F3FFC9C-C4D1-41A6-AFDE-891C4E4DB04EQ34787024-9E219199-E123-4142-BC3F-8568684B92ECQ35031828-5D9674BF-922A-4097-96D1-42EF681FA790Q35043366-DCDAE861-93D2-4B2B-9923-44F3F77AE495Q35044973-407BFC1D-6F81-44D2-B9D1-7A5DC83EF4BE
P2860
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@ast
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@en
type
label
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@ast
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@en
prefLabel
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@ast
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@en
P2093
P356
P1476
Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition.
@en
P2093
Goodwin DC
Kalgutkar AS
Marnett LJ
Rowlinson SW
P304
22903-22906
P356
10.1074/JBC.274.33.22903
P407
P577
1999-08-01T00:00:00Z